The incidence of the primary end point was:
Death occurred in 5.7 percent of the patients assigned to angioplasty and 7.0 percent of those assigned to t-PA (P=0.37).
Reinfarction in 4.5 percent and 6.5 percent (P=0.13).
Disabling stroke in 0.2 percent and 0.9 percent (P=0.11).
The primary end point was observed in 10.6 percent of the patients in the angioplasty group assigned to heparin and 8.2 percent of those assigned to hirudin (P=0.37).
There was no significant difference in outcome at six months.
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.